West Pharmaceutical Services, Inc. (WST) Tops Q4 EPS by 4c, Offers FY12 EPS Outlook
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $327.95 --0%
Revenue Growth %: +9.5%
Financial Fact:
Selling, general and administrative expenses: 58.3M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +9.5%
Financial Fact:
Selling, general and administrative expenses: 58.3M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q4 EPS of $0.59, $0.04 better than the analyst estimate of $0.55. Revenue for the quarter came in at $295.4 million versus the consensus estimate of $290.05 million.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
West Pharmaceutical Services, Inc. sees FY2012 EPS of $2.37-$2.55, versus the consensus of $2.51.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Seacoast Banking (SBCF) PT Raised to $34 at Piper Sandler
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
